Diskussionsleitung: I. Fleming (Frankfurt am Main), U. Kintscher (Berlin)
(P1379) | Atherosclerosis licenses for an exceeding immune response in COVID-19 disease | |
J. Leberzammer, W. Abplanalp, K. Grikscheit, S.-F. Glaser, B. Schumacher, M. Merten, M.-T. Katschke, M. Bendel, D. John, M. Vehreschild, S. Ciesek, D. Leistner, A. M. Zeiher, S. Dimmeler, S. Cremer (Frankfurt am Main) | ||
(P1380) | Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10 | |
V. Henscke, K. Hild, E. Schilling, J. Haas, V. Filipova, S. Erbe, R. König, J. Hübschen, U. Laufs, C. Claus, J.-N. Boeckel (Leipzig, Heidelberg; Esch-sur-Alzette, LU) | ||
(P1381) | Microplastics lead to endothelial and epithelial inflammation | |
F. Brüstle, N. Trippel, A.-K. Vlacil, B. Schieffer, K. Grote (Marburg) | ||
(P1382) | Normoxische HIF-1α-Stabilisierung durch lokale inflammatorische Faktoren verändert das endotheliale Sekretom und fördert die Dysfunktion der endothelialen Barriere | |
M. Abdi Sarabi, A. Shiri, S. Medunjanin, S. Weinert, R. Braun-Dullaeus (Magdeburg) | ||
(P1383) | The cardiovascular effects of alternative tobacco products and the role of phagocytic NADPH oxidase (NOX-2) | |
P. Stamm, D. Mihalikova, A. Czarnowski, S. Rajilic, M. Kuntic, I. Kuntic, O. Hahad, H. Ubbens, L. Strohm, M. Oelze, S. Steven, A. Daiber, T. Münzel (Mainz) | ||
(P1384) | The vitamin-k-cycle-enzyme VKORC1L1, but not its isoenzyme VKORC1, reduces inflammation in coronary endothelial cells | |
E. Repges, M. Al Zaidi, F. Jansen, S. Zimmer, V. Tiyerili, G. Nickenig, A. Aksoy (Bonn, Dortmund) | ||
(P1385) | Endothelial cannabinoid receptor 1 upregulation by pro-atherogenic shear stress promotes vascular inflammation. | |
A. Prabhu, B. Chen, S. Steffens (München) | ||
(P1386) | The endoplasmic reticulum (ER) chaperone GRP78 is secreted during ER Stress and alleviates endothelial cell inflammation | |
E. Repges, M. Al Zaidi, F. Jansen, S. Zimmer, V. Tiyerili, G. Nickenig, A. Aksoy (Bonn, Dortmund) |